Trial Profile
The efficacy and safety of adding tocilizumab to methotrexate and intra-articular glucocorticosteroid treatment in early rheumatoid arthritis. A randomized, double-blinded, placebo-controlled trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Dec 2017
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms DanACT-Early
- 23 Dec 2017 Status changed from recruiting to completed.
- 28 Jun 2012 New trial record